Exercise of Share Options and Total Voting Rights

RNS Number : 7396T

Aquis Exchange PLC

26 November 2021

 

26 November 2021

Aquis Exchange PLC

("Aquis" or the "Company")

Exercise of Share Options

and

Total Voting Rights

Aquis Exchange PLC (AIM: AQX), the exchange services group, announces that it has received notification that certain employees have exercised options under the Company's EMI Option Scheme over 1,859 ordinary shares of 10p each in the Company ("Ordinary Shares") at an exercise price of £2.69 per Ordinary Share and 1,333 Ordinary Shares at an exercise price of £3.55 per Ordinary Share.

Application has been made for 3,192 new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 29 November 2021. The new Ordinary Shares will rank pari pasu with the existing Ordinary Shares in issue.

Total Voting Rights

In accordance with the provisions of the Disclosure Guidance and Transparency Rules of the FCA, the Company confirms that, following this issue, its issued share capital will comprise 27,505,449 Ordinary Shares. All Ordinary Shares shall have equal voting rights and none of the Ordinary Shares are held in treasury. Accordingly, the figure of 27,505,449 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Aquis Exchange PLC	Tel: [phone]
Belinda Keheyan, Head of Marketing
Liberum Capital Limited (Nominated Adviser and Joint Broker)	Tel: [phone]
Chris Clarke
Clayton Bush
Edward Thomas
Kane Collings
Canaccord Genuity Limited (Joint Broker)	Tel: [phone]
Bobbie Hilliam (Corporate Broking)
Alma PR (Financial PR Adviser)	Tel: [phone]
Susie Hudson	[e-mail]
Kieran Breheny
Faye Calow

Notes to Editors

About Aquis Exchange

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK and in EU27 respectively. Aquis operates a lit order book and does not allow aggressive non-client proprietary trading, which has resulted in lower toxicity and signalling risk on Aquis than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. Aquis uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. AQSE, which used to be known as NEX Exchange Ltd., was acquired by Aquis in March 2020 from CME Inc. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to    www.aquis.eu

 

END

 

 

TVRDZMZMLVKGMZG